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JLME COLUMN

The Ethical Health Lawyer
Watch Out for
Whistleblowers
Leslie Griffin

"There's a new whistleblower in
Washington," according to CNN
News. He is Food and Drug Administration scientist David Graham,
who claims that the FDA failed to
warn the public about certain drugs'
dangerous side effects and pressured him to change his research's
conclusion that the arthritis drug
Vioxx caused heart attacks.2 Another
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Washington whistleblower, Dr.
Jonathan Fishbein of the National
Institutes of Health, alleged that he
was fired because "he had raised concerns about sloppy practices that
might endanger patient safety" in a3
study of the AIDS drug nevirapine.
Graham and Fishbein thus joined
the ranks of whistleblowers who
have gained some prominence in recent years for their reporting of corporate or institutional misconduct.
The best-known whistleblowersthe FBI's Coleen Rowley, Enron's
Sherron Watkins, and WorldCom's
Cynthia Cooper, who together received Time magazine's Whistleblower Person of the Year Award in
20024 - focused public attention on
the reform of corporate accounting
and legal practices. The Graham
and Fishbein examples, however,
provide a timely reminder to the
ethical health lawyer to be prepared
for whistleblowers. State and federal law's treatment of health care
whistleblowers is comprehensive
and complex. Wise health lawyers
will anticipate the whistleblowers in
their midst and establish appropriate
programs and procedures to prevent
both misconduct and retaliation long
before the whistleblower's story appears on CNN.
Retaliation Against
Whistleblowers
Whistleblowers are individuals who
report misconduct; they frequently
face retaliation for doing so. Important legal questions about retaliation
arise whenever an employee who re-

ports misconduct is fired or demoted. Unfortunately, this law of
wrongful or retaliatory discharge is
a mess: "piecemeal," "patchwork,"
5
The general rule is
"hodgepodge."

at-will employment, namely that an
employee may be fired at the employer's will without recourse for
job termination or demotion. State
courts and legislatures, however,
have enacted numerous exceptions
to this rule, offering remedies to, for
example, government (but not private company) whistleblowers,
whistleblowers whose reporting involves important questions of public
policy or safety, or whistleblowers
who refuse to perform an illegal
activity.6 In federal law, the False
Claims Act, which lets private parties
who discover federal health care program fraud file qui tam suits on the
government's behalf and receive a
percentage of the government's proceeds, also protects against individuals being "discharged, demoted,
suspended, threatened, harassed, or
in any other manner discriminated
against" for participating in the fraud
investigations. 7 Some combination
of damages such as reinstatement,
back pay, costs and attorney's fees is
available under these federal and
state standards.
Thus step one for the ethical
health lawyer is to understand the
numerous laws that govern retaliation against whistleblowers in the
jurisdiction. Several federal statutes
are directed explicitly at medical
whistleblowers.8 Moreover, even
states whose courts disfavor private
whistleblower lawsuits may have legislation that affords special protection to medical care facility employees. 9

Once the universe of whistleblower law is identified, the scope
Leslie Griffin, J.D., Ph.D., holds the Larry
& JoanneDoherty Chair in Legal Ethics at
the University ofHouston Law Center.

JOURNAL OF LAW, MEDICINE & ETHICS

HeinOnline -- 33 J.L. Med. & Ethics 160 2005

Leslie Griffin

of protection against retaliation
remains contested. In Dr. Fishbein's
NIH case, for example, the United
States Merit Systems Protection
Board ruled recently that the
Whistleblower Protection Act did
not protect the doctor because he
was a probationary, "Title 42" employee to whom the provisions of the
act did not apply.10 The United States
Supreme Court is also examining the
range of whistleblower protection
this term. In a non-medical case,
Roderick Jackson, the male coach of
a girls' high school basketball team,
allegedly lost his coaching job after
reporting that the girls' team did not
receive equal funding or access. Jackson filed suit for retaliation under
Title IX, the federal legislation that
prohibits sex discrimination in education, but the Eleventh Circuit dismissed his lawsuit on the grounds
that Title IX does not provide a private right of action for whistleblowers who report gender discrimination but are not subjected to it
personally." The Jackson decision
may clarify the protection afforded
to whistleblowers under numerous
federal statutes; it also raises anew
the recurring issues of at-will employment and statutory protection
against retaliation. Piecemeal, patchwork, hodgepodge, developing, uncertain - the specific law of retaliatory discharge requires careful study.
Reporting Misconduct
by Whistleblowers
Journalistic and literary descriptions
of whistleblowers often focus on the
moral and personal factors that persuade them to risk their careers and
report misconduct. Reporting also
poses equal challenges for the health
lawyer. Over the last three years, corporate lawyers have been forced to
recognize that retaliation lawsuits
are not their only worry about
whistleblowers. After Enron and
other corporate scandals, Congress
passed the Sarbanes-Oxley Act,
which, in addition to prohibiting retaliation against whistleblowers, requires publicly traded companies to
set up internal mechanisms that
allow employees to report misconduct and establishes criminal penal-

ties for employers if retaliation occurs. 12 Although Sarbanes-Oxley applies only to publicly traded companies, its treatment of whistleblowers
provides a model of "best practices"
for other industries, including private and non-profit health care or1 3
ganizations.
In addition to the Act's protection
of employees against retaliation, the
two other whistleblower provisions

hundreds of doctors to prescribe
17
Neurontin for non-approved uses."'

Accountants Jim Alderson and
John Schilling detected fraudulent
Medicare reimbursements at Columbia/HCA and cooperated with
the government to uncover the
fraud.' Franklin received a $26.6
million settlement from Pfizer, while
Alderson and Schilling split $100
million. 19

State and federal law treatment of health care
whistleblowers is comprehensive and complex.
Wise health lawyers will anticipate the
whistleblowers in their midst and establish
appropriate programs and procedures to prevent
both misconduct and retaliation long before the
whistleblower's story appears on CNN.
named above are noteworthy. First,
like corporate lawyers, health
lawyers should establish procedures
that give employees the occasion to
report wrongdoing without fear of
reprisal and employers the opportunity to cure misconduct. Because
Sarbanes-Oxley did not specify those
procedures, lawyers must consider
carefully what reporting mechanisms - internal or external, anonymous or non-anonymous - will be
most effective.14 Second, SarbanesOxley's criminalization of retaliation
against whistleblowers "represents
a momentous departurefrom the
state statutes, as well as the Model
[Whistleblower] Act."' 5 Those criminal sanctions are not limited to publicly traded companies, but "seem16
ingly encompass every employer."'
The securities legislation thus raises
the question whether criminal sanctions for employers will grow in importance as a means to police institutional misconduct and punish
retaliation in every industry.
There have been numerous
whistleblowers in the health care
industry. In addition to Graham
and Fishbein, for example, David
Franklin reported that Pfizer marketed the epilepsy drug Neurontin
for non-FDA approved purposes
and "gave financial incentives to
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Not all whistleblowers are so successful. Sometimes they are mistaken, and even when they are correct they can be "quirky,anxious and
irritable."2° Indeed, a leading book
on whistleblowers profiles them as
"psychological narcissists" 2 1; in simpler language, they can be just the
kind of person everyone wants to
avoid. Nonetheless, the ethical
health lawyer must listen to the
whistle and then ensure that the
whistleblower's complaint is reported, recorded and rectified while
the whistleblower's person never
faces retaliation.
Avoiding settlements or litigation,
and complying with Sarbanes-Oxley,
however, are not the only reasons for
ethical health lawyers to heed the
whistleblower; in this field, the
whistleblower may warn of serious
dangers to life and health. In learning about such risks, the lawyer
comes face to face with the whistleblower's dilemma, namely whether

to report the harm or to decide that
loyalty to clients

requires that

lawyers never blow the whistle.
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